Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DHEA + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (Placebo Controlled, Double Blind and Randomized Phase III Study to Evaluate the Effects of 12-Week Treatment With DHEA (Prasterone) and Acolbifene on Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women)

NCT01452373 is registered in ClinicalTrials.gov with EndoCeutics Inc. as lead sponsor.

NCT NCT01452373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01452373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DHEA + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (Placebo Controlled, Double Blind and Randomized Phase III Study to Evaluate the Effects of 12-Week Treatment With DHEA (Prasterone) and Acolbifene on Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women)
Lead sponsor
EndoCeutics Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2013
Enrollment
238 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hot flushes, vasomotor symptoms